Trials / Completed
CompletedNCT02544893
Postoperative Analgesic Effects of Using Dexmedetomidine for Ultrasound Guided Thoracic Paravertebral Block
Postoperative Analgesic Effects of Using Bupivacaine Alone or Added Dexmedetomidine for Ultrasound Guided Thoracic Paravertebral Block in Thoracotomy
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 93 (actual)
- Sponsor
- TC Erciyes University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
we aimed postoperative analgesic effects of using bupivacaine alone or added dexmedetomidine for ultrasound guided thoracic paravertebral block in thoracotomy
Detailed description
paravertebral block is commonly used in the treatment for acute and chronic pain.The duration of paravertebral block could theoretically be prolonged with neurolytic agents. Dexmedetomidine ,an alfa-2 adrenoreceptor agonist, is being used and adjuvant capable of prolonging duration of sensory and motor block on nerve blocks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | bupivacaine | 21 ml 0.5 %bupivacaine is applied paravertebral space |
| DRUG | dexmedetomidin | 1 ml dexmedetomidin + 20 ml 0.5 % bupivacaine are applied paravertebral space |
| DRUG | serum physiologic | 21 ml serum physiologic is applied paravertebral space |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2016-03-01
- Completion
- 2016-03-01
- First posted
- 2015-09-09
- Last updated
- 2016-08-03
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT02544893. Inclusion in this directory is not an endorsement.